Project Grant HT9425261E203
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
- Federal Project Grant Award Summary Purdue University received a $144,244 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research to develop animal models and identify therapeutic vulnerabilities associated with radiation-induced angiosarcoma, a malignant cancer that can develop following radiation exposure. This research initiative...
- The Defense Health Agency awarded Purdue University a $1,294,062 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop evidence-based behavioral health practices. The grant, awarded on June 15, 2023, will fund a 4-year project titled "Turning Training into Action: Translating Training of Behavioral Health Providers into Evidence-Based Practices." Through this award, Purdue University will serve as the prime recipient, with sub-awards to...
- Federal Project Grant Award Summary The University of Washington received a $769,887 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on preventing per- and polyfluoroalkyl substances (PFAS) neurotoxicity through folate pathway intervention. The award was issued on May 15, 2026, with a performance period extending through May 14, 2029. Research activities will be conducted at the University of...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $144,254.00 to Purdue University to conduct research on "ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN EPITHELIOID HEMANGIOENDOTHELIOMA." The award period runs from Aug 15, 2024 to Aug 14, 2026. As a prominent research university, Purdue University has extensive experience supporting U.S. government missions through federal contracts and...
- Federal Grant Award Summary Asedasciences Inc. received a $1,050,320 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with an ultimate completion date of September 29, 2028. The awardee will develop a high-throughput cellular and biomimetic screening platform integrated with machine learning analytics and data visualization capabilities designed to assess neurotoxicity risk. This platform...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $1,508,132 to the University of Rhode Island Research Office through the Military Medical Research and Development program (CFDA 12.420) to conduct research on the use of bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS) levels and improve serum lipid profiles in veterans. The four-year project, initiated on September 30, 2025 and scheduled for completion by September 29, 2029,...
- The Department of the Army Medical Command awarded Purdue University a $2,431,591 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2026 to study the Role of Comorbid Military-Relevant Stressors in Osteoarthritis. Through this award, Purdue University researchers will investigate the impact of psychological and physiological stress experienced by military service members on the development...
- Federal Project Grant Award Summary The University of Illinois has been awarded $555,100 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year project commencing August 1, 2025 and concluding July 31, 2028. The project, titled "Testicular Germ Cell Tumors as a Sentinel Cancer of PFAS Exposure," supports advanced biomedical research investigating the relationship between perfluoroalkyl and polyfluoroalkyl substances...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $621,779 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The grant funds research titled "Modulating Immune Stress Pathways as a Strategy for CIPN Prevention and Cancer Management," conducted at the institution's Winston-Salem, North Carolina facility. This three-year award...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. a Project Grant totaling $864,434 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on PFAS (Per- and Polyfluoroalkyl Substances) and other toxic military exposures and their association with pancreatic cancer risk in a military population. The award, effective September 30, 2025, with an ultimate...